Current trends in multiple sclerosis research: an update on pathogenic concepts

Joris Vanderlocht1, Niels Hellings, Jerome J A Hendriks

  • 1Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium.

Acta Neurologica Belgica
|February 28, 2007
PubMed

Insights

Multiple sclerosis (MS) is an autoimmune central nervous system (CNS) disease influenced by genetics and environment. This review updates pathogenic concepts, discusses axonal loss, and explores CD8+ T cell roles in MS tissue injury.

Area of Science:

  • Neurology
  • Immunology
  • Pathogenesis

Background:

  • Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune disease affecting the central nervous system (CNS).
  • MS pathogenesis involves genetic susceptibility and environmental triggers.
  • Current understanding requires updates on disease mechanisms.

Purpose of the Study:

  • To provide an update on the basic pathogenic concepts of MS.
  • To discuss evolving concepts including pathogenic heterogeneity and axonal loss.
  • To highlight the role of CD8+ T lymphocytes in MS-related tissue injury.

Main Methods:

  • This is a review article.
  • Literature review of basic and evolving pathogenic concepts in MS.
  • Summary of current and emerging therapeutic approaches.

Main Results:

  • Pathogenic heterogeneity is an evolving concept in MS.
  • Axonal loss is a critical component of MS pathology.
  • CD8+ T lymphocytes play a significant role in CNS tissue injury in MS.

Conclusions:

  • Understanding MS pathogenesis is crucial for developing effective treatments.
  • New insights into MS pathology, including immune cell roles and tissue damage, are emerging.
  • Current treatments and promising therapeutic strategies are under evaluation.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.